Publications

Treatment resistance to platinum-based chemotherapy in lung and ovarian cancer is driven by a targetable TGFβ senescent secretome.

Authors:

E-pub date: 3 Feb 2026

Journal name: Nat Aging

MDC1 counteracts replication fork reversal and mediates chemosensitivity in BRCA1/2-deficient tumors.

Authors: H Dogan, M Liptay, JS Barbosa, E Gogola, AA Duarte, JA Schmid, I Klebic, M ...

E-pub date: 1 Feb 2026

Journal name: Oncogene

5-methylcytosine and 5-hydroxymethylcytosine are synergistic biomarkers for early detection of colorectal cancer.

Authors: F Puddu, A Johansson, A Modat, J Scotcher, R Sethi, S Yu, N Harding, M Hill...

E-pub date: 20 Jan 2026

Journal name: Commun Med (Lond)

CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance.

Authors: A Watterson, G Picco, V Veninga, Y Samarakoon, CM Cattaneo, SF Vieira, E Ka...

E-pub date: 20 Jan 2026

Journal name: Cell Rep Med

Lung Metastases in Pancreatic Cancer: Timing Their First Breath.

Authors: G Mucciolo, G Biffi

E-pub date: 2 Jan 2026

Journal name: Cancer Res

Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancer.

Authors: FLA Kwong, C Kristunas, C Davenport, J Deeks, S Mallett, R Agarwal, S Kehoe...

E-pub date: 1 Jan 2026

Journal name: Int J Gynecol Cancer

Decay of driver mutations shapes the landscape of intestinal transformation.

Authors: FC Lourenço, ID Sadien, K Wong, S Adler, A Sawle, LS Santana, L Hazelwood,...

E-pub date: 1 Jan 2026

Journal name: Nature

Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models.

Authors: M Schoof, T Zheng, M Sill, R Imle, A Cais, L Altendorf, A Fürst, N Hofmann...

E-pub date: 1 Jan 2026

Journal name: Nat Genet

Filters

Research Groups

Core Facilities

Start date

End date

Treatment resistance to platinum-based chemotherapy in lung and ovarian cancer is driven by a targetable TGFβ senescent secretome.

MDC1 counteracts replication fork reversal and mediates chemosensitivity in BRCA1/2-deficient tumors.

5-methylcytosine and 5-hydroxymethylcytosine are synergistic biomarkers for early detection of colorectal cancer.

CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance.

Lung Metastases in Pancreatic Cancer: Timing Their First Breath.

Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancer.

Decay of driver mutations shapes the landscape of intestinal transformation.

Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Treatment resistance to platinum-based chemotherapy in lung and ovarian cancer is driven by a targetable TGFβ senescent secretome.

MDC1 counteracts replication fork reversal and mediates chemosensitivity in BRCA1/2-deficient tumors.

5-methylcytosine and 5-hydroxymethylcytosine are synergistic biomarkers for early detection of colorectal cancer.

CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance.

Lung Metastases in Pancreatic Cancer: Timing Their First Breath.

Symptom-triggered testing detects early stage and low volume resectable advanced stage ovarian cancer.

Decay of driver mutations shapes the landscape of intestinal transformation.

Investigation of a global mouse methylome atlas reveals subtype-specific copy number alterations in pediatric cancer models.